Pulmonx (LUNG) Revenue Growth (1y) (2020 - 2025)
Pulmonx (LUNG) Revenue Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn | 7.78% |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn | 2.63% |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn | 11.58% |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn | 16.70% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 15.05% |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn | 7.41% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn | 6.08% |
| 10 | Pulmonx | 50.56 Mn | -19.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5.47% |
| Jun 30, 2025 | 14.80% |
| Mar 31, 2025 | 19.54% |
| Dec 31, 2024 | 23.28% |
| Sep 30, 2024 | 15.39% |
| Jun 30, 2024 | 20.87% |
| Mar 31, 2024 | 29.71% |
| Dec 31, 2023 | 24.98% |
| Sep 30, 2023 | 30.85% |
| Jun 30, 2023 | 23.25% |
| Mar 31, 2023 | 34.77% |
| Dec 31, 2022 | 12.53% |
| Sep 30, 2022 | 1.82% |
| Jun 30, 2022 | 14.32% |
| Mar 31, 2022 | 16.67% |
| Dec 31, 2021 | 39.45% |
| Sep 30, 2021 | 24.96% |
| Jun 30, 2021 | 232.24% |
| Mar 31, 2021 | 7.26% |
| Dec 31, 2020 | -5.00% |